Clinical Trials Logo

Vaginal Discharge clinical trials

View clinical trials related to Vaginal Discharge.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05557318 Recruiting - Vaginitis Clinical Trials

Using Micro Electro Mechanical Systems to Detect the Air of Vaginal Discharge

Start date: October 8, 2022
Phase: N/A
Study type: Interventional

This clinical study aims to train the algorithm and assess the performance of the Ainos Flora Women's Vaginal Health Tester in identifying vaginal infections.

NCT ID: NCT04885556 Recruiting - Dyspareunia Clinical Trials

Evaluation of a Novel Female Hygiene Device for Postcoital Discomfort

Start date: April 5, 2021
Phase: N/A
Study type: Interventional

Previous research has shown that semen deposition in the vagina after intercourse leads to dripping, discomfort, and vaginal odor. This study is evaluating a hygiene device designed to be inserted into the vagina after intercourse to absorb semen deposited into the vaginal canal to determine if there is a reduction in dripping and odor, and to determine the amount of fluids absorbed.

NCT ID: NCT04719754 Recruiting - Vaginal Infection Clinical Trials

Epidemiology of Abnormal Vaginal Discharge During Pregnancy

Start date: June 1, 2021
Phase:
Study type: Observational

Vaginitis among women of childbearing age is well acknowledged as a public health concern due to its high occurrence. Vulvovaginitis is a disorder of the vulva and/or vagina caused by infection, inflammation, or changes in the flora. There are many types of infections that affect the vagina, the most common three types of infection: bacterial vaginosis, trichomoniasis, and candidiasis. Bacterial vaginosis is the most common vaginal infection in women of reproductive age causing thin and milky vaginal discharge with a fishy odor. Trichomoniasis causes a frothy, greenish-yellow discharge with a foul smell. Vaginal Candidiasis is one of the most common fungal infections of the female genital tract and the second most common vaginal infection affecting women of reproductive age (after the bacterial infection worldwide. It affects more than 75% of women at least once in their lifetime, with approximately 50% of them also suffering a single recurrence. About 75% of patients suffering from candidiasis are asymptomatic, but it may be symptomatic with clinical picture characterized by itching, vaginal pain, vulvar burning sensation, dyspareunia, dysuria and mildly unpleasant odor, erythema and vulvar edema, white-yellowish plaques on the walls of the vagina and cervix and cheesy vaginal discharge. The risk of vulvo-vaginal candidiasis increases by 30% during pregnancy also in pregnancy, the presence of vaginitis is related to abortion, intrauterine infection, fetal growth retardation, premature rupture of membranes, preterm birth, low birth weight, puerperal infection, and other adverse pregnancy outcomes.

NCT ID: NCT02898818 Recruiting - Healthy Clinical Trials

Vaginal and Oral Microbiome Crosstalk

Start date: April 19, 2017
Phase:
Study type: Observational [Patient Registry]

To study the vaginal and oral microbiome by swab samples. On selected cases, also papa smear will be studied.